ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 42 filers reported holding ALIGOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,724 | -23.1% | 92,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $89,332 | +11.1% | 92,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $80,408 | -24.7% | 92,000 | -17.9% | 0.00% | -33.3% |
| Q4 2022 | $106,725 | +22.7% | 112,000 | +41.8% | 0.00% | +50.0% |
| Q3 2022 | $87,000 | +26.1% | 79,000 | +38.6% | 0.00% | 0.0% |
| Q2 2022 | $69,000 | – | 57,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $2,253,090 | 2.67% |
| TANG CAPITAL MANAGEMENT LLC | 3,329,048 | $3,232,506 | 0.48% |
| Vivo Capital, LLC | 3,547,030 | $3,444,166 | 0.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $721,662 | 0.24% |
| Newtyn Management, LLC | 900,000 | $873,900 | 0.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $613,562 | 0.19% |
| EcoR1 Capital, LLC | 3,948,360 | $3,833,858 | 0.09% |
| HHLR ADVISORS, LTD. | 2,309,764 | $2,242,781 | 0.05% |
| Baker Brothers Advisors | 2,076,400 | $2,016,184 | 0.01% |
| HARBOURVEST PARTNERS LLC | 18,783 | $18,238 | 0.01% |